X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JYOTHY LABS with AMAR REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JYOTHY LABS vs AMAR REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JYOTHY LABS AMAR REMEDIES JYOTHY LABS/
AMAR REMEDIES
 
P/E (TTM) x 43.9 -0.5 - View Chart
P/BV x 9.4 0.1 15,544.0% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 JYOTHY LABS   AMAR REMEDIES
EQUITY SHARE DATA
    JYOTHY LABS
Mar-16
AMAR REMEDIES
Jun-12
JYOTHY LABS/
AMAR REMEDIES
5-Yr Chart
Click to enlarge
High Rs342164 208.5%   
Low Rs23786 275.6%   
Sales per share (Unadj.) Rs90.9261.6 34.7%  
Earnings per share (Unadj.) Rs8.717.4 50.1%  
Cash flow per share (Unadj.) Rs10.522.3 46.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs46.7100.7 46.4%  
Shares outstanding (eoy) m181.1226.16 692.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.20.5 666.5%   
Avg P/E ratio x33.27.2 461.9%  
P/CF ratio (eoy) x27.75.6 493.7%  
Price / Book Value ratio x6.21.2 499.4%  
Dividend payout %57.30-   
Avg Mkt Cap Rs m52,4343,270 1,603.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,661163 1,019.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m16,4666,844 240.6%  
Other income Rs m10321 488.1%   
Total revenues Rs m16,5686,865 241.3%   
Gross profit Rs m2,2441,131 198.4%  
Depreciation Rs m314128 245.3%   
Interest Rs m60398 15.2%   
Profit before tax Rs m1,973626 315.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-50 0.0%   
Tax Rs m393121 324.8%   
Profit after tax Rs m1,580455 347.2%  
Gross profit margin %13.616.5 82.5%  
Effective tax rate %19.919.3 103.1%   
Net profit margin %9.66.6 144.3%  
BALANCE SHEET DATA
Current assets Rs m4,5364,904 92.5%   
Current liabilities Rs m8,6413,581 241.3%   
Net working cap to sales %-24.919.3 -129.0%  
Current ratio x0.51.4 38.3%  
Inventory Days Days40124 32.6%  
Debtors Days Days21100 20.8%  
Net fixed assets Rs m10,7571,689 636.9%   
Share capital Rs m181262 69.1%   
"Free" reserves Rs m7,7222,358 327.5%   
Net worth Rs m8,4612,635 321.1%   
Long term debt Rs m73507 14.3%   
Total assets Rs m17,6736,862 257.5%  
Interest coverage x33.72.6 1,310.3%   
Debt to equity ratio x00.2 4.5%  
Sales to assets ratio x0.91.0 93.4%   
Return on assets %9.312.4 74.6%  
Return on equity %18.717.3 108.1%  
Return on capital %23.831.0 76.8%  
Exports to sales %0.74.0 18.7%   
Imports to sales %1.50-   
Exports (fob) Rs m123273 45.0%   
Imports (cif) Rs m242NA-   
Fx inflow Rs m123273 45.0%   
Fx outflow Rs m2692 13,462.0%   
Net fx Rs m-146271 -54.0%   
CASH FLOW
From Operations Rs m1,915-313 -612.7%  
From Investments Rs m3-489 -0.7%  
From Financial Activity Rs m-3,025769 -393.6%  
Net Cashflow Rs m-1,107-33 3,404.6%  

Share Holding

Indian Promoters % 66.8 25.5 261.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.4 9.2 91.7%  
FIIs % 14.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.3 65.3 15.8%  
Shareholders   84,983 13,061 650.7%  
Pledged promoter(s) holding % 36.7 99.7 36.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JYOTHY LABS With:   MARICO LTD  RELAXO FOOTWEARS  BATA INDIA  ARCHIES LTD  GILLETTE INDIA  

Compare JYOTHY LABS With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

Aug 9, 2017

While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

Aug 9, 2017

While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

P&G: Strong Core Growth (Quarterly Results Update - Detailed)

Dec 9, 2016

Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

Nestle India: Sales Traction From New Products (Quarterly Results Update - Detailed)

Nov 30, 2016

Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JYOTHY LABS SHARE PRICE


May 21, 2018 (Close)

TRACK JYOTHY LABS

  • Track your investment in JYOTHY LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

JYOTHY LABS 5-YR ANALYSIS

COMPARE JYOTHY LABS WITH

MARKET STATS